Atlas Trials

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Clinical trial NCT02156544 · COMPLETED

Trial details

NCT number
NCT02156544
Sponsor
Chong Kun Dang Pharmaceutical
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2014-06-01
Primary completion
2014-10-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.